|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
40,510,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SI-BONE is a medical device company. Co. has a proprietary minimally invasive surgical implant system, which it calls iFuse, to address sacroiliac joint dysfunction and degeneration, adult deformity, pelvic ring traumatic fractures. Co.'s iFuse Implant System includes a series of patented triangular implants and the instruments Co. has developed to enable surgeons to perform the procedures using different surgical approaches for different indications. Co. has introduced iFuse-3D, its other implant. This patented titanium implant combines the triangular cross-section of the iFuse Classic implant with the proprietary 3D-printed porous surface and a fenestrated design.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
22,856 |
94,402 |
239,744 |
666,595 |
Total Sell Value |
$355,754 |
$1,854,443 |
$4,918,414 |
$13,818,404 |
Total People Sold |
4 |
6 |
7 |
8 |
Total Sell Transactions |
10 |
18 |
38 |
75 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Yerby Scott A |
Chief Technology Officer |
|
2019-10-16 |
4 |
AS |
$15.82 |
$3,512 |
D/D |
(222) |
9,545 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-10-15 |
4 |
AS |
$16.30 |
$178,223 |
I/I |
(10,936) |
90,779 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-10-01 |
4 |
AS |
$17.71 |
$17,713 |
D/D |
(1,000) |
18,854 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-10-01 |
4 |
OE |
$4.32 |
$4,320 |
D/D |
1,000 |
19,854 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-09-19 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
9,896 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-09-19 |
4 |
OE |
$3.96 |
$19,800 |
D/D |
5,000 |
14,896 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-09-19 |
4 |
AS |
$20.00 |
$6,000 |
D/D |
(300) |
18,854 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-09-19 |
4 |
OE |
$4.32 |
$1,296 |
D/D |
300 |
19,154 |
|
- |
|
Dunn Jeffrey W |
Chairman, President & CEO |
|
2019-09-16 |
4 |
AS |
$19.08 |
$486,399 |
I/I |
(25,497) |
467,540 |
|
- |
|
Dunn Jeffrey W |
Chairman, President & CEO |
|
2019-09-13 |
4 |
AS |
$19.16 |
$277,931 |
I/I |
(14,503) |
493,037 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-09-03 |
4 |
AS |
$18.98 |
$22,771 |
D/D |
(1,200) |
18,854 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-09-03 |
4 |
OE |
$4.32 |
$5,184 |
D/D |
1,200 |
20,054 |
|
- |
|
Skyline Venture Management V, Llc |
|
|
2019-08-26 |
4 |
S |
$18.40 |
$2,805,181 |
I/I |
(152,424) |
3,819,985 |
|
- |
|
Freund John Gordon |
|
|
2019-08-26 |
4 |
S |
$18.40 |
$2,805,181 |
I/I |
(152,424) |
3,819,985 |
|
- |
|
Freund John Gordon |
|
|
2019-08-23 |
4 |
S |
$20.03 |
$3,605 |
I/I |
(180) |
3,972,409 |
|
- |
|
Skyline Venture Management V, Llc |
|
|
2019-08-23 |
4 |
S |
$20.03 |
$3,605 |
I/I |
(180) |
3,972,409 |
|
- |
|
Freund John Gordon |
|
|
2019-08-22 |
4 |
S |
$20.05 |
$43,807 |
I/I |
(2,185) |
3,972,589 |
|
- |
|
Skyline Venture Management V, Llc |
|
|
2019-08-22 |
4 |
S |
$20.05 |
$43,807 |
I/I |
(2,185) |
3,972,589 |
|
- |
|
Freund John Gordon |
|
|
2019-08-21 |
4 |
S |
$20.14 |
$911,057 |
I/I |
(45,211) |
3,974,774 |
|
- |
|
Skyline Venture Management V, Llc |
|
|
2019-08-21 |
4 |
S |
$20.14 |
$911,057 |
I/I |
(45,211) |
3,974,774 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-21 |
4 |
AS |
$20.03 |
$15,421 |
D/D |
(770) |
9,896 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-21 |
4 |
OE |
$3.96 |
$3,049 |
D/D |
770 |
10,666 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-08-21 |
4 |
AS |
$20.13 |
$103,410 |
I/I |
(5,138) |
101,715 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-20 |
4 |
AS |
$20.01 |
$78,629 |
D/D |
(3,930) |
9,896 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-20 |
4 |
OE |
$3.96 |
$15,563 |
D/D |
3,930 |
13,826 |
|
- |
|
440 Records found
|
|
Page 14 of 18 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|